Business Wire
BusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessUPS says its reorganization will lean more heavily on global logistics than domestic parcel operationsThe Apex TimesBusinessGeneral Dynamics shares fall more than the broader market in late-session tradingThe Apex TimesBusinessEli Lilly to buy Merdia Biosciences in a deal valued at up to $2.88 billion, indicating renewed focus on pipeline expansionThe Apex TimesBusinessNvidia hardware momentum meets a new choke point: copper, not cash, HIVE Digital’s Frank Holmes saysThe Apex TimesBusinessBroadcom’s Sept. 2 earnings set up a high-stakes test for its AI narrativeThe Apex TimesBusinessPalantir CEO Alex Karp pushes back on “tokenmaxxing,” pitching real-world AI value over hypeThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging inflated prices in online ads schemeThe Apex TimesBusinessTesla shares rise after investors refocus on long-term autonomous driving potentialThe Apex TimesBusinessTim Cook’s final day as Apple CEO caps a 15-year push into services, wearables and paymentsThe Apex TimesBusinessNetflix announces new original comedy led by Camila Pitanga and Sergio GuizéThe Apex TimesBusinessWall Street stays upbeat on GE Aerospace after the shares outpace the NasdaqThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessUPS says its reorganization will lean more heavily on global logistics than domestic parcel operationsThe Apex TimesBusinessGeneral Dynamics shares fall more than the broader market in late-session tradingThe Apex TimesBusinessEli Lilly to buy Merdia Biosciences in a deal valued at up to $2.88 billion, indicating renewed focus on pipeline expansionThe Apex TimesBusinessNvidia hardware momentum meets a new choke point: copper, not cash, HIVE Digital’s Frank Holmes saysThe Apex TimesBusinessBroadcom’s Sept. 2 earnings set up a high-stakes test for its AI narrativeThe Apex TimesBusinessPalantir CEO Alex Karp pushes back on “tokenmaxxing,” pitching real-world AI value over hypeThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging inflated prices in online ads schemeThe Apex TimesBusinessTesla shares rise after investors refocus on long-term autonomous driving potentialThe Apex TimesBusinessTim Cook’s final day as Apple CEO caps a 15-year push into services, wearables and paymentsThe Apex TimesBusinessNetflix announces new original comedy led by Camila Pitanga and Sergio GuizéThe Apex TimesBusinessWall Street stays upbeat on GE Aerospace after the shares outpace the NasdaqThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessUPS says its reorganization will lean more heavily on global logistics than domestic parcel operationsThe Apex TimesBusinessGeneral Dynamics shares fall more than the broader market in late-session tradingThe Apex TimesBusinessEli Lilly to buy Merdia Biosciences in a deal valued at up to $2.88 billion, indicating renewed focus on pipeline expansionThe Apex TimesBusinessNvidia hardware momentum meets a new choke point: copper, not cash, HIVE Digital’s Frank Holmes saysThe Apex TimesBusinessBroadcom’s Sept. 2 earnings set up a high-stakes test for its AI narrativeThe Apex TimesBusinessPalantir CEO Alex Karp pushes back on “tokenmaxxing,” pitching real-world AI value over hypeThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging inflated prices in online ads schemeThe Apex TimesBusinessTesla shares rise after investors refocus on long-term autonomous driving potentialThe Apex TimesBusinessTim Cook’s final day as Apple CEO caps a 15-year push into services, wearables and paymentsThe Apex TimesBusinessNetflix announces new original comedy led by Camila Pitanga and Sergio GuizéThe Apex TimesBusinessWall Street stays upbeat on GE Aerospace after the shares outpace the NasdaqThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessUPS says its reorganization will lean more heavily on global logistics than domestic parcel operationsThe Apex TimesBusinessGeneral Dynamics shares fall more than the broader market in late-session tradingThe Apex TimesBusinessEli Lilly to buy Merdia Biosciences in a deal valued at up to $2.88 billion, indicating renewed focus on pipeline expansionThe Apex TimesBusinessNvidia hardware momentum meets a new choke point: copper, not cash, HIVE Digital’s Frank Holmes saysThe Apex TimesBusinessBroadcom’s Sept. 2 earnings set up a high-stakes test for its AI narrativeThe Apex TimesBusinessPalantir CEO Alex Karp pushes back on “tokenmaxxing,” pitching real-world AI value over hypeThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging inflated prices in online ads schemeThe Apex TimesBusinessTesla shares rise after investors refocus on long-term autonomous driving potentialThe Apex TimesBusinessTim Cook’s final day as Apple CEO caps a 15-year push into services, wearables and paymentsThe Apex TimesBusinessNetflix announces new original comedy led by Camila Pitanga and Sergio GuizéThe Apex TimesBusinessWall Street stays upbeat on GE Aerospace after the shares outpace the NasdaqThe Apex Times
Back to front
Costco adds Medicare plans with SCAN Group, raising questions about the next leg of its healthcare strategy
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 21, 7:42 PM EDT

Costco adds Medicare plans with SCAN Group, raising questions about the next leg of its healthcare strategy

A new partnership with SCAN Group will bring Costco-branded Medicare Advantage and supplement coverage to select states, extending the retailer’s health-care footprint beyond traditional pharmacy and membership benefits. Analysts are also asking how investors should think about the move’s financial significance.

Costco Wholesale is moving further into health insurance through a partnership with SCAN Group, according to an Aug. 21 report by Yahoo Finance. The retailer plans to roll out Costco-branded Medicare Advantage and Medicare supplement plans in select states, adding a new line of business adjacent to the company’s existing pharmacy and care services.

The Medicare Advantage plans are a Medicare replacement option offered by private insurers, while Medicare supplement plans help pay certain out-of-pocket costs not covered by Original Medicare. By putting its name on these products, Costco is effectively using its membership base and retail footprint as distribution channels for coverage that is typically sold through insurers and broker networks.

The deal also reflects a broader shift in U.S. retail where consumer brands look for recurring-fee or recurring-revenue opportunities tied to healthcare. For Costco, which already operates a pharmacy business and provides health-related perks for members, the insurance partnership represents an expansion of services that may deepen member stickiness.

Still, the Yahoo Finance piece frames the move in the context of valuation, asking whether Costco stock is “fully valued” for the incremental benefit investors might be expecting. That question matters because healthcare products can change a retailer’s earnings mix, but the market often demands clarity on customer acquisition economics, risk management, and the durability of any new revenue streams.

What Costco did not disclose in the Yahoo report is as important as what it did. The report describes the planned Medicare Advantage and supplement rollouts and notes the SCAN Group partnership, but it does not provide, at least in the text available here, key implementation details such as which states will be first, expected timelines for expansion, pricing, or the financial impact on Costco’s earnings in the near term.

For now, investors will likely focus on how quickly Costco-branded plans gain enrollment, how pricing and member risk are handled over time, and whether the company’s retail scale translates into profitable insurance growth. Those factors typically determine whether a healthcare partnership becomes a meaningful long-term earnings driver or remains a smaller strategic add-on.

Looking ahead, the next checkpoints are likely to include regulatory and program disclosures tied to Medicare Advantage and supplement offerings, plus any company updates on rollout scope and enrollment performance. Until then, the practical question for the market is not only whether the partnership expands Costco’s healthcare reach, but whether it does so on economics that can justify the valuation expectations embedded in the stock.

Why It Matters

  • Costco’s entry into Medicare-branded coverage could add a higher-frequency, recurring element to its healthcare ecosystem if enrollment grows meaningfully.
  • Because Medicare products depend on pricing discipline and risk management, the profitability of the partnership will likely be a key determinant of whether it moves the needle financially.
  • A retailer-led distribution strategy could intensify competition in select Medicare markets, potentially affecting insurer economics and consumer choice.
  • The valuation question indicates that investors may require clearer disclosure on rollout progress and financial contribution before fully crediting the partnership.

Sources

Key Facts

  • Costco Wholesale has partnered with SCAN Group to roll out Costco-branded Medicare Advantage and Medicare supplement plans.
  • The plans are intended for customers in select states, as described in an Aug. 21 Yahoo Finance report.
  • Medicare Advantage is a Medicare alternative provided by private insurers, while Medicare supplement coverage helps cover certain costs not paid by Original Medicare.
  • The Yahoo Finance report explicitly frames the development through a valuation lens, asking whether the stock is fully priced for this new Medicare-related initiative.

Retail & Consumer Related

Aug 31, 2:06 PM EDT
The Apex Times

Walmart climbs as oil at $90 bolsters the “defensive” appeal of retailers

Investors are treating cheaper-to-own retail as a buffer again, after a sharp move in crude oil toward $90. The shift could help Walmart capture shoppers “trading down,” but higher fuel and inventory costs also pose a risk to the cash profits that support its valuation.

Walmart climbs as oil at $90 bolsters the “defensive” appeal of retailers
The Apex Times
Costco adds Medicare plans with SCAN Group, raising questions about the next leg of its healthcare strategy | The Apex Times